Company Analysis Bausch Health Companies Inc.
1. Summary
Advantages
- Price (7.88 $) is less than fair price (8.9 $)
- The stock's return over the last year (-13.25%) is higher than the sector average (-15.65%).
- The company's current efficiency (ROE=57.93%) is higher than the sector average (ROE=-80.86%)
Disadvantages
- Dividends (0%) are below the sector average (1.29%).
- Current debt level 81.86% has increased over 5 years from 76.47%.
Similar companies
2. Share price and performance
2.1. Share price
2.2. News
2.3. Market efficiency
| Bausch Health Companies Inc. | Healthcare | Index | |
|---|---|---|---|
| 7 days | -5.7% | -13.6% | 2.7% |
| 90 days | -11.8% | -21.4% | 4.9% |
| 1 year | -13.2% | -15.7% | 25.6% |
BHC vs Sector: Bausch Health Companies Inc. has outperformed the "Healthcare" sector by 2.41% over the past year.
BHC vs Market: Bausch Health Companies Inc. has significantly underperformed the market by -38.83% over the past year.
Stable price: BHC is not significantly more volatile than the rest of the market on "New York Stock Exchange" over the last 3 months, with typical variations of +/- 5% per week.
Long period: BHC with weekly volatility of -0.2548% over the past year.
3. Summary of the report
4. Fundamental Analysis
4.1. Stock price and price forecast
Below fair price: The current price (7.88 $) is lower than the fair price (8.9 $).
Price not significantly lower than the fair price: The current price (7.88 $) is slightly lower than the fair price by 12.9%.
4.2. P/E
P/E vs Sector: The company's P/E (10.68) is lower than that of the sector as a whole (57.86).
P/E vs Market: The company's P/E (10.68) is lower than that of the market as a whole (47.62).
4.2.1 P/E Similar companies
4.3. P/BV
P/BV vs Sector: The company's P/BV (-33.15) is lower than that of the sector as a whole (9.39).
P/BV vs Market: The company's P/BV (-33.15) is lower than that of the market as a whole (22.59).
4.4. P/S
P/S vs Sector: The company's P/S indicator (0.3104) is lower than that of the sector as a whole (4.06).
P/S vs Market: The company's P/S indicator (0.3104) is lower than that of the market as a whole (15.2).
4.4.1 P/S Similar companies
4.5. EV/Ebitda
EV/Ebitda vs Sector: The company's EV/Ebitda (8.36) is lower than that of the sector as a whole (17.55).
EV/Ebitda vs Market: The company's EV/Ebitda (8.36) is lower than that of the market as a whole (19.68).
5. Profitability
5.1. Profitability and revenue
5.2. Earnings per share - EPS
5.3. Past profitability Net Income
Yield Trend: Rising and has grown by 1.14% over the last 5 years.
Earnings Slowdown: The last year's return (0%) is below the 5-year average return (1.14%).
Profitability vs Sector: The return for the last year (0%) exceeds the return for the sector (-66.62%).
5.4. ROE
ROE vs Sector: The company's ROE (57.93%) is higher than that of the sector as a whole (-80.86%).
ROE vs Market: The company's ROE (57.93%) is higher than that of the market as a whole (18.07%).
5.5. ROA
ROA vs Sector: The company's ROA (-2.16%) is lower than that of the sector as a whole (6.71%).
ROA vs Market: The company's ROA (-2.16%) is lower than that of the market as a whole (6.49%).
5.6. ROIC
ROIC vs Sector: The company's ROIC (0%) is lower than that of the sector as a whole (15.68%).
ROIC vs Market: The company's ROIC (0%) is lower than that of the market as a whole (9.31%).
7. Dividends
7.1. Dividend yield vs Market
Low yield: The dividend yield of the company 0% is below the average for the sector '1.29%.
7.2. Stability and increase in payments
Dividend stability: The company's dividend yield 0% has been steadily paid over the past 7 years, DSI=0.79.
Weak dividend growth: The company's dividend yield 0% has been growing weakly or stagnant over the past 5 years. Growth over only 1 year.
7.3. Payout percentage
Dividend Coverage: Current payments from income (0%) are at an uncomfortable level.
Pay for your subscription
More functionality and data for company and portfolio analysis is available by subscription
